A stem cell therapy patented by Sankara Nethralaya may help treat patients with corneal ulcers

"The cells that are cultivated within the Mebiol Gel can be used for therapeutic purposes, instead of human tissues like the amniotic membrane," said Dr H N Madhavan, President, Vision Research Foundation, and Director and Professor of Microbiology, Sankara Nethralaya. "We received a patent in July for the process... It was a great struggle to get the patent, with challenges posed by many countries... and the next step is to take up human trial."
The price of the procedure is yet to be decided, but Dr Madhavan said the Gel costs Rs 5,000.
Source-Medindia